Pulmonary Disease, Chronic Obstructive clinical trials
Access comprehensive clinical trial information for Pulmonary Disease, Chronic Obstructive through Pure Global AI's free database. This collection includes 715 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 40 trials are actively recruiting participants.
Research for Pulmonary Disease, Chronic Obstructive is being conducted in United States of America, United Kingdom, Germany and 7+ other countries. Leading sponsors include GlaxoSmithKline and Boehringer Ingelheim. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 715 clinical trials studying Pulmonary Disease, Chronic Obstructive, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, among others.